364 results on '"Heidenreich, Paul A."'
Search Results
2. Uptake of Sodium-Glucose Cotransporter-2 Inhibitors in Hospitalized Patients With Heart Failure: Insights From the Veterans Affairs Healthcare System
3. Heart failure management guidelines: New recommendations and implementation
4. Geographic Variation in the Quality of Heart Failure Care Among U.S. Veterans
5. As We Embark on a Second Year
6. Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines – Heart Failure Registry
7. Heart Failure Epidemiology and Outcomes Statistics A Report of the Heart Failure Society of America
8. Variation in Methamphetamine-Associated Heart Failure Hospitalizations Across the United States
9. Pharmacist- and Nurse-Led Medical Optimization in Heart Failure: A Systematic Review and Meta-Analysis
10. PO-04-224 PRACTICE VARIATION AFTER AMBULATORY ECG DETECTION OF NON-SUSTAINED VENTRICULAR TACHYCARDIA IN THE NON-CARDIAC PATIENT
11. Opportunities for Change in Home Health Care in Heart Failure
12. Clinical and echocardiographic diversity associated with physical fitness in the Project Baseline Health Study: implications for heart failure staging
13. The Value of Comprehensive Guideline-Directed Therapy for Heart Failure With Reduced Ejection Fraction
14. Association of CHA2DS2-VASc and HAS-BLED to Frailty and Frail Outcomes: From the TREAT-AF Study
15. The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology
16. MORTALITY IN HEART FAILURE WITH INDETERMINATE KIDNEY DISEASE
17. PREVALENCE AND PROGNOSTIC VALUE OF VENTRICULAR TACHYCARDIA ON AMBULATORY ECG MONITORING
18. METHAMPHETAMINE ASSOCIATED HEART FAILURE HOSPITALIZATIONS AMONG VETERANS IN THE UNITED STATES
19. Predictors of Incident Heart Failure Diagnosis Setting
20. Can We Attribute Outcome Improvements to Improved Cardiac Imaging?
21. Treatment Differences in Medical Therapy for Heart Failure With Reduced Ejection Fraction Between Sociodemographic Groups
22. The patient-reported outcome measurement in heart failure clinic trial: Rationale and methods of the PRO-HF trial
23. Variation in Cost of Echocardiography Within and Across U.S. Hospitals
24. Temporal Trends in Gender of Principal Investigators and Patients in Cardiovascular Clinical Trials
25. Use of lipid-lowering therapy preceding first hospitalization for acute myocardial infarction or stroke
26. Medical therapy for patients with recent-onset heart failure with reduced ejection fraction during the COVID-19 pandemic: Insights from the Veteran's affairs healthcare system
27. Weight Loss and Cardiac Reverse Remodeling
28. Health System–Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial
29. Expenditure on Heart Failure in the United States
30. Clinical predictors of improvement in left ventricular ejection fraction in U.S. veterans with heart failure
31. Temporal shift and predictive performance of machine learning for heart transplant outcomes
32. Regional variations in the process of care for patients undergoing percutaneous coronary intervention in Japan
33. 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure
34. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
35. Performance On Guideline Directed Medical Therapy Remains Low In A Cluster-randomized Trial: Results From CONNECT-HF
36. Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure
37. Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure
38. Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines – Atrial Fibrillation (GWTG-AFIB) registry
39. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
40. Economic Issues in Heart Failure in the United States
41. Harnessing the Potential of Primary Care Pharmacists to Improve Heart Failure Management
42. Cost and Value in Contemporary Heart Failure Clinical Guidance Documents
43. Systematic Quantification of Sources of Variation in Ejection Fraction Calculation Using Deep Learning
44. Cardiovascular procedural deferral and outcomes over COVID-19 pandemic phases: A multi-center study
45. Time to Relax the 40-Year Age Threshold for Pharmacologic Cholesterol Lowering
46. High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better
47. Renin–angiotensin–aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system
48. Inpatient versus outpatient intravenous diuresis for the acute exacerbation of chronic heart failure
49. Medicare in the Age of COVID: A Case Study in HFSA Advocacy
50. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.